Hans Loibner,Oliver Mutschlechner,Ruth Ladenstein,Isabel Klier
申请号：
US16375022
公开号：
US20200055953A1
申请日:
2019.04.04
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Preparations and methods for treating a GD2 positive cancer by administering a preparation comprising an anti-GD2 antibody to a patient, wherein the patient is not concomitantly treated with Interleukin-2 (IL-2), and wherein one or more treatment periods with the antibody may be preceded, accompanied, and/or followed by one or more treatment periods with a retinoid.
